What is bad about the RNS?11 Jun 2020 09:29
What a confusing board for supposed shareholder ....
1. CF said he would sign one this week - he has and told us
2. CF told us he had another near term - I would expect at least another one this month
3. CF told us Covid challenge studies are £6m - £7m with at 30% - 40% margin - this is a vaccine contract - where else is the focus so I assume it is
4. It is an existing contract, account expansion is always easier than new name sales
5. How does anyone interpret signing a major contract as bad news, move on, next investor presentation 10th July
So Link have cleared (at least mostly), part of placement is effective, RNS underpins SP and shows progress, £10.1m savings in the year.
I am not sure what more people want from the company in a matter of weeks .... could to have Pharma contracts for challenge studies when you have a Flu vaccine company to sell!